EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency

Annie Siyu Wu iD, Lee Mozessohn, Richard B Kim iD, Jonathan S Zipursky

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70047 ↗

Kurz gefasst

Fallbericht in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Annie Siyu Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Alopecia, Azathioprine, Chemical and Drug Induced Liver Injury, Immunosuppressive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thiopurines are a class of immunosuppressant and antineoplastic agents. They are widely used in the treatment of inflammatory bowel disease, haematological malignancies and autoimmune diseases, but can cause significant toxicity. Inherited gene mutations are now recognized as independent risk factors for severe adverse drug reactions to thiopurines even at 10‐fold dose reductions. We present a case of thiopurine toxicity resulting in severe myelosuppression, hepatotoxicity and alopecia in an individual with homozygous *3/*3 loss‐of‐function alleles in the NUDT15 gene. Our case highlights important differences in gene mutation frequencies between races that can help guide pharmacogenomic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlopeciaAzathioprineChemical and Drug Induced Liver InjuryImmunosuppressive AgentsMercaptopurinePyrophosphatasesHumansLoss of Function MutationNudix Hydrolases

Stichwörter der Autor:innen

NUDT15TPMTadverse drug reactionsthiopurine toxicity

Substanzen

AzathioprineImmunosuppressive AgentsMercaptopurineNUDT15 protein, humanPyrophosphatasesNudix Hydrolases

Autor:innen und Institutionen

  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Division of Medical Oncology/Hematology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Department of Medicine, University of Western Ontario, London, Ontario, Canada.
  • Division of Clinical Pharmacology and Toxicology, London Health Sciences Center, London, Ontario, Canada.
  • Division of General Internal Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

ORCID-Profile: Annie Siyu Wu, Richard B Kim

Zitieren

APA

Wu, A. S., Mozessohn, L., Kim, R. B., & Zipursky, J. S. (2025). Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70047

Vancouver

Wu AS, Mozessohn L, Kim RB, Zipursky JS. Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70047

BibTeX
@article{Wu2025,
  author = {Wu, Annie Siyu and Mozessohn, Lee and Kim, Richard B and Zipursky, Jonathan S},
  title = {Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70047}
}
Kostenlos starten →